| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS20040934 | HPV | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS20061048 | HPV | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS20061003 | HPV | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44016565 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44004697 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44011443 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44045452 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44039305 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44039304 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
| TVIS44039303 | HTLV-1 | ENSG00000118515.12 | protein_coding | SGK1 | Yes | No | 6446 | E9PR89 O00141 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | SGK1 |
|---|---|
| DrugBank ID | DB03247 |
| Drug Name | Flavin mononucleotide |
| Target ID | BE0004105 |
| UniProt ID | O00141 |
| Regulation Type | |
| PubMed IDs | 10592235 |
| Citations | Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Approved; Investigational |
| Direct Classification | Flavin nucleotides |
| SMILES | CC1=CC2=C(C=C1C)N(C[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O)C1=NC(=O)NC(=O)C1=N2 |
| Pathways | Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency); Dihydropyrimidinase Deficiency; Hyperornithinemia with Gyrate Atrophy (HOGA); Riboflavin Metabolism; Carnosinuria, Carnosinemia; MNGIE (Mitochondrial Neurogastrointestinal Encephalopathy); Hyperprolinemia Type II; Pantothenate and CoA Biosynthesis; beta-Ureidopropionase Deficiency; Hypophosphatasia; L-Arginine:Glycine Amidinotransferase Deficiency; Vitamin B6 Metabolism; Hyperornithinemia-Hyperammonemia-Homocitrullinuria [HHH-syndrome]; Doxorubicin Metabolism Pathway; UMP Synthase Deficiency (Orotic Aciduria); Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency); Prolidase Deficiency (PD); Pyrimidine Metabolism; Creatine Deficiency, Guanidinoacetate Methyltransferase Deficiency; Ornithine Aminotransferase Deficiency (OAT Deficiency); beta-Alanine Metabolism; Hyperprolinemia Type I; Nitric Oxide Signaling Pathway; Arginine and Proline Metabolism; GABA-Transaminase Deficiency; Ureidopropionase Deficiency; Prolinemia Type II |
| PharmGKB | |
| ChEMBL | CHEMBL1201794 |
